Clinical Trials · NCT01634321
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Enrollment
- 63
- Start date
- Jul 2011
- Locations
- 1 site, South Korea
- Primary endpoint
- At 24 weeks, percentage of subjects with suppression of peak-stimulated Luteinizing Hormone (LH) concentrations